BENGALURU (Reuters) – India’s Panacea Biotec Ltd said on Thursday it had agreed to produce up to 25 million doses of the Sputnik V COVID-19 vaccine using the drug substance made by Russia’s Generium.
Panacea will then supply the doses to drugmaker Dr. Reddy’s Laboratories for distribution in India. (https://bit.ly/3joeloz)
(Reporting by Anuron Kumar Mitra in Bengaluru; Editing by Shailesh Kuber)
